ROTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 108
EU - Europa 73
AS - Asia 50
SA - Sud America 6
AF - Africa 1
Totale 238
Nazione #
US - Stati Uniti d'America 105
IE - Irlanda 32
IT - Italia 22
SG - Singapore 21
CN - Cina 12
DE - Germania 10
HK - Hong Kong 7
BR - Brasile 5
TR - Turchia 4
GB - Regno Unito 3
VN - Vietnam 3
CA - Canada 2
FI - Finlandia 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
IL - Israele 1
IN - India 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
Totale 238
Città #
Dublin 32
Chandler 24
Singapore 15
Santa Clara 10
Jacksonville 8
Ashburn 7
Hong Kong 7
Boardman 6
New York 6
Munich 5
Lawrence 3
Los Angeles 3
Nanjing 3
Princeton 3
Rome 3
Seattle 3
Wilmington 3
Bremen 2
Dong Ket 2
L'aquila 2
Pescara 2
Toronto 2
Ann Arbor 1
Araçatuba 1
Berlin 1
Brno 1
Changsha 1
Chieti 1
Dallas 1
Falls Church 1
Fremont 1
Fuzhou 1
Haikou 1
Handan 1
Hanoi 1
Helsinki 1
Izmir 1
Kenitra 1
Kunming 1
L’Aquila 1
Mallet 1
Manila 1
Mountain View 1
Ningbo 1
Panama City 1
Porto Alegre 1
Pune 1
San Juan de Lurigancho 1
San Mateo 1
Tel Aviv 1
Valparaíso de Goiás 1
Venda Nova do Imigrante 1
Warsaw 1
Totale 182
Nome #
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2 98
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 44
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 44
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects 39
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (364), 10.1186/s13046-021-02154-8) 13
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 5
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 4
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 3
Totale 250
Categoria #
all - tutte 1.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 1 0 0 1
2020/202127 0 1 0 1 1 0 1 18 1 0 2 2
2021/202215 1 0 0 0 0 1 1 0 2 2 1 7
2022/202379 3 5 1 11 5 6 0 4 34 1 5 4
2023/202430 2 1 2 2 1 14 0 1 0 2 2 3
2024/202572 3 6 8 9 7 12 16 11 0 0 0 0
Totale 250